Market News Research Screener Watchlist

FATE Fate Therapeutics, Inc.

Healthcare

$2.25+7.14%ClosedMarket Cap: $262.3M

As of 2026-05-25

Overview Financials Analyst Insider Congress ETF & Holdings Dividends Earnings Comments

No congress trading data available for FATE.

Data provided for informational purposes only. Not financial advice.

© 2026 InvestLog AI